← Search & browse all drugs
CARDIOVASCULAR SYSTEM › DIURETICS › LOW-CEILING DIURETICS, EXCL. THIAZIDES › Sulfonamides and potassium in combination
chlortalidone and potassium
C03BB04
Forms & Strengths
- Chlortalidone 15 mg / Potassium chloride 600 mg equivalent to 8 mEq K+
- Chlortalidone 25 mg / Potassium chloride 600 mg equivalent to 8 mEq K+
Adult Dosing
- Hypertension: 1 tablet daily, adjusted based on clinical response and serum potassium levels
- Edema: 1 to 2 tablets daily as a single dose, adjusted according to patient response
Pediatric Dosing
- Safety and efficacy in pediatric patients have not been established
Indications
- Management of hypertension, alone or in combination with other antihypertensive agents
- Management of edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid or estrogen therapy
- Prophylaxis of hypokalemia in patients requiring chlortalidone diuretic therapy
Mechanism of Action
- Chlortalidone inhibits sodium and chloride reabsorption at the cortical diluting segment of the distal renal tubule, increasing excretion of sodium, water, chloride, and potassium
- Potassium chloride matrix provides a slow-release source of potassium ions to mitigate the hypokalemic effect induced by the thiazide-like diuretic
Contraindications
- Anuria
- Hypersensitivity to chlortalidone, other sulfonamide-derived drugs, or potassium chloride
- Conditions associated with hyperkalemia, such as renal impairment (severe), untreated Addison's disease, acute dehydration, and simultaneous use of potassium-sparing diuretics
Adverse Reactions
- Hypokalemia or hyperkalemia, electrolyte imbalances (hyponatremia, hypomagnesemia, hypercalcemia)
- Hypotension, dizziness, orthostatic hypotension
- Hyperuricemia, gout exacerbation, hyperglycemia
- Gastrointestinal irritation, nausea, diarrhea, abdominal pain (associated with potassium chloride)
- Photosensitivity, rash, paresthesia
Drug Interactions
- Lithium: Decreased renal clearance, increasing the risk of lithium toxicity
- ACE inhibitors, ARBs, or potassium-sparing diuretics: Significantly increased risk of severe hyperkalemia due to combined potassium retention
- NSAIDs: May decrease the diuretic, natriuretic, and antihypertensive effects of chlortalidone and increase nephrotoxicity
- Digitalis glycosides: Diuretic-induced hypokalemia or hypomagnesemia increases the risk of digitalis toxicity and arrhythmias
Curated Content: Needs Vetting Before Put to Clinical Use